CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Budapest, Hungary and 83 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Budapest, Hungary and 209 other locations
This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small...
Phase 3
Budapest, Hungary and 54 other locations
cemiplimab or docetaxel in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
Budapest, Hungary and 33 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Budapest, Hungary and 137 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Budapest, Hungary and 205 other locations
INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC)....
Phase 3
Budapest, Hungary and 140 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Budapest, Hungary and 230 other locations
In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...
Phase 3
Törökbálint, Hungary and 17 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Tatabánya, Hungary and 168 other locations
Clinical trials
Research sites
Resources
Legal